Quantifying the efficacy of influenza vaccines

The Lancet Infectious Diseases

Volumn 12, Issue 9, 2012, Pages 659-660

  Soriano, Alessandra ^a   Manna, Raffaele ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADVERSE OUTCOME; AUTOIMMUNE DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG SAFETY; GERMANY; GIANT CELL ARTERITIS; GROUPS BY AGE; GUILLAIN BARRE SYNDROME; HEALTH CARE POLICY; INFLAMMATION; INFLUENZA VACCINATION; INFORMATION RETRIEVAL; LETTER; MEDLINE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SWINE INFLUENZA; UNITED KINGDOM; UNITED STATES; VACCINATION REACTION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INFLUENZAVIRUS A; INFLUENZAVIRUS B;

EID: 84865296980     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70183-4     Document Type: Letter

References (6)

1. Osterholm MT, Kelley NS, Sommer A, Belongia EA Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
2. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5:648-652.
3. Lehmann HC, Harthug HP, Kieseier BC, Hughes RA Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis 2010, 10:643-651.
4. Shoenfeld Y, Agmon-Levin N 'ASIA'-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011, 36:4-8.
5. Soriano A, Verrecchia E, Marinaro A, et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus 2012, 21:153-157.
6. Kelly H, Valenciano M Estimating the effect of influenza vaccines. Lancet Infect Dis 2012, 12:5-6.